Clinical Trials Browser

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Stomach Neoplasms, Endometrial Neoplasms

NCT05207787 2023-06-01

Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

306 enrolled

Other solid neoplasm

Solid Tumor

NCT05862831 2023-05-17

Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors

Phase 1/2 Unknown

285 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05833984 2023-04-27

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Phase 1/2 Unknown

309 enrolled

LymphoidOther solid neoplasm

Solid Tumor

NCT04571892 2023-04-12

A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors

Phase 1/2 Unknown

58 enrolled

Other solid neoplasm

Malignant Solid Tumor

NCT05805956 2023-04-10

IMM2902 in Patients With Advanced Solid Tumors Expressing HER2

Phase 1/2 Unknown

105 enrolled

GastrointestinalOther solid neoplasmThoracic

Advanced Solid Tumor

NCT05434299 2023-03-16

A Study of TFX05-01 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

36 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

747 enrolled

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05748938 2023-03-01

A Study of RD14-01 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

12 enrolled

Other solid neoplasm

Solid Tumor

NCT05740215 2023-02-22

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

Phase 1/2 Unknown

158 enrolled

Other solid neoplasm

Solid Tumors

NCT05688605 2023-01-18

A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors

Phase 1/2 Unknown

18 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05645315 2022-12-09

Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

127 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04450901 2022-12-05

Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

90 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05338957 2022-12-01

A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.

Phase 1/2 Unknown

30 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT05598268 2022-10-28

A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Phase 1/2 Unknown

74 enrolled

GastrointestinalLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Liver Neoplasms, Lung Neoplasms, Lymphoma

NCT04765462 2022-10-04

Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors

Phase 1/2 Unknown

60 enrolled

Other solid neoplasm

Malignant Solid Tumours

NCT05457517 2022-09-27

A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

49 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04843709 2022-09-08

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

Phase 1/2 Unknown

181 enrolled

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Phase 1/2 Unknown

272 enrolled

Other solid neoplasm

Solid Tumors

NCT05508659 2022-08-19

A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors

Phase 1/2 Unknown

128 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05332574 2022-08-05

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Phase 1/2 Unknown

120 enrolled

Other solid neoplasmThoracic

NSCLC

NCT05478785 2022-07-29

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors

Phase 1/2 Unknown

126 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT03758664 2022-07-06

Clinical Study of ICP-192 in Solid Tumors Patients

Phase 1/2 Unknown

56 enrolled

Other solid neoplasm

Solid Tumor

NCT05425602 2022-06-21

A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors

Phase 1/2 Unknown

108 enrolled

Other solid neoplasm

Advanced / Metastatic Solid Tumors

NCT05216965 2022-06-15

A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors

Phase 1/2 Unknown

208 enrolled

Other solid neoplasm

Solid Tumors

NCT05258266 2022-03-14

A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors

Phase 1/2 Unknown

76 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04679038 2022-01-26

A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

222 enrolled

Other solid neoplasm

Solid Tumor

NCT05119933 2021-11-15

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

Phase 1/2 Unknown

55 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT04937842 2021-06-24

Microtransplantation for Advanced and Relapsed Solid Tumors

Phase 1/2 Unknown

60 enrolled

Other solid neoplasm

Solid Tumors

Clinical Trials

A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

IMMINENT-01

A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.

Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation

Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors

ALG.APV-527 First-in-human Study

BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

ICEMELT

Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors

Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors

IMM2902 in Patients With Advanced Solid Tumors Expressing HER2

A Study of TFX05-01 in Patients With Advanced Solid Tumors

REGOMUNE

A Study of RD14-01 in Patients With Advanced Solid Tumors

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors

Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors

Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.

A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors

A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

6MW3511 in Patients With Advanced Solid Tumor

A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors

Clinical Study of ICP-192 in Solid Tumors Patients

A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors

A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors

A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors

A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

Microtransplantation for Advanced and Relapsed Solid Tumors